Please log in to view this page
Username
Password
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
